吉尼胺通过向STAT3-HK2-介导的糖解来缓解纤维化
Rui Shi1,2, Meng-Qian Liu1,2, Jian-Ping Xiao1,2
1Department of Nephrology, the Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, 230601, Anhui, China.
BMC complementary medicine and therapies
|October 10, 2025
概括
基尼化物 (GP) 通过抑制STAT3/HK2信号传递和葡萄糖代谢来预防纤维化. 这项研究调查了GP的调查.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
背景情况:
- 来自Gardenia jasminoides的Geniposide (GP) 具有药理作用,包括潜在的脏保护.
- 在缓解单边尿路阻塞 (UUO) 诱导的干纤维化及其潜在机制的GP的有效性仍然在很大程度上未被探索.
- 这项研究调查了GP在纤维化中的保护作用和机制.
研究的目的:
- 在体内评估Geniposide (GP) 对单边尿路阻塞 (UUO) 诱导的间纤维化治疗效果.
- 阐明GP作用的潜在分子机制,重点关注STAT3/HK2信号通路和葡萄糖代谢.
- 用转化生长因子β1 (TGF-β1) 治疗的HK-2细胞在体外验证这些发现.
主要方法:
- 建立了UUO的小鼠模型,小鼠接受了GP的治疗.
- 用HE染色,马森染色和免疫组织化学评估损伤和纤维化.
- 使用高通量测序,KEGG分析,西式抹杀和分子对接来研究涉及STAT3/HK2通路的机制. 在体外研究中使用了具有STAT3过度表达的HK-2细胞.
主要成果:
- 在UUO小鼠中,GP治疗显著缓解了纤维化.
- 通过与STAT3结合,GP抑制糖解,减少STAT3的酸化和核转移,并调节与糖解相关的蛋白HK2.
- 在体外,GP阻止了HK-2细胞的TGF-β1诱导的上皮转移到介质细胞 (EMT),而这些效应被STAT3过度表达逆转.
结论:
- 基尼胺 (GP) 显示出对纤维化的保护作用.
- 在UUO诱导的损伤中,GP通过抑制STAT3/HK2信号通路来发挥其保护作用,从而调节葡萄糖代谢.
- 医生代表了纤维化的潜在治疗药物.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
921
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
1.9K
相关概念视频
01:20The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K